The process that results in activated platelet-related thrombosis in myeloproliferative neoplasms includes intrinsic platelet abnormalities due to transformed haematopoietic stem cell function that brings about overactive JAK2-dependent signaling and various extrinsic factors. This evidence concerns the gene JAK2 and myeloproliferative disorder.